Cite
Screening of Glypican-6 Expression in Benign, Primary and Metastatic Colon Cancers.
MLA
Al-Saraireh, Yousef M., et al. “Screening of Glypican-6 Expression in Benign, Primary and Metastatic Colon Cancers.” Clinical Medicine Insights: Oncology, Aug. 2021, pp. 1–7. EBSCOhost, https://doi.org/10.1177/11795549211036419.
APA
Al-Saraireh, Y. M., Alshammari, F. O., Youssef, A. M., Al-Sarayreh, S., Al-Sarayra, Y. M., Aborajooh, E., Al-Shuneigat, J., & Alrawashdeh, H. M. (2021). Screening of Glypican-6 Expression in Benign, Primary and Metastatic Colon Cancers. Clinical Medicine Insights: Oncology, 1–7. https://doi.org/10.1177/11795549211036419
Chicago
Al-Saraireh, Yousef M, Fatemah OFO Alshammari, Ahmed MM Youssef, Sameeh Al-Sarayreh, Yahya M Al-Sarayra, Emad Aborajooh, Jehad Al-Shuneigat, and Hamzeh M Alrawashdeh. 2021. “Screening of Glypican-6 Expression in Benign, Primary and Metastatic Colon Cancers.” Clinical Medicine Insights: Oncology, August, 1–7. doi:10.1177/11795549211036419.